Medicine guide

Celldemic

·

  • Prescription status not stated
  • Antibiotics, antivirals and antifungals taken into the body
Made by
Seqirus Netherlands B.V.

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

  • Celldemic is indicated for active immunisation against H5N1 subtype of Influenza A virus in adults and infants from 6 months of age and above. Celldemic should be used in accordance with official recommendations.

From the official label · 2026-09-30 · European Medicines Agency

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

BulgariaNo exact match for this strength and form

SpainNo exact match for this strength and form

CanadaNo exact match for this strength and form

NetherlandsNo exact match for this strength and form

SwitzerlandNo exact match for this strength and form

Details

Made bySeqirus Netherlands B.V.
Active substanceZoonotic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted, prepared in cell cultures)
Used inAntibiotics, antivirals and antifungals taken into the body
ClassificationJ07BB02 · Antibiotics, antivirals and antifungals taken into the body
Additional monitoring ▼Yes — under additional monitoring (black triangle). Report suspected side effects.
Authorised on2024-04-19
Last updated by the regulator2026-09-25
EMA product numberEMEA/H/C/006052

Source: European Medicines Agency — medicine data · 2026-09-30 · not reviewed by a clinician

Source: European Medicines Agency (EMA). Product information as published by EMA. Reuse terms: EMA legal notice (reproduction authorised).